(Q36905879)

17 August 2017

1 reference

title

Adjunctive treatment of acute mania: a clinical overview (English)

1 reference

17 August 2017

Sachs GS

1

1 reference

17 August 2017

Gardner-Schuster EE

series ordinal

2

1 reference

17 August 2017

publication date

1 January 2007

1 reference

Acta psychiatrica Scandinavica. Supplementum

17 August 2017

published in

1 reference

17 August 2017

issue

434

1 reference

17 August 2017

page(s)

27-34

1 reference

Mood stabilizer combinations: a review of safety and efficacy

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01056.X

Comparison of lithium carbonate and chlorpromazine in the treatment of mania. Report of the Veterans Administration and National Institute of Mental Health Collaborative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01056.X

Use of antipsychotic drugs and lithium in mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01056.X

Extended-release carbamazepine capsules as monotherapy in bipolar disorder : pooled results from two randomised, double-blind, placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01056.X

Topiramate monotherapy in the management of acute mania: results of four double-blind placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01056.X

Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzipine HGGW Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01056.X

Risperidone in the treatment of acute mania: double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01056.X

Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01056.X

Ziprasidone in acute bipolar mania: a 21-day randomized, double-blind, placebo-controlled replication trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01056.X

Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01056.X

Quetiapine or haloperidol as monotherapy for bipolar mania--a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01056.X

Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01056.X

A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01056.X

Olanzapine versus divalproex in the treatment of acute mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01056.X

Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01056.X

Carbamazepine but not valproate induces bupropion metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01056.X

Gabapentin in bipolar disorder: a placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01056.X

Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01056.X

Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01056.X

Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01056.X

Quetiapine with lithium or divalproex for the treatment of bipolar mania: a randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01056.X

Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01056.X

A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-0447.2007.01056.X

10.1111/J.1600-0447.2007.01056.X

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference